Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy
Thomas Jefferson University
Thomas Jefferson University
City of Hope Medical Center
Thomas Jefferson University
Barbara Ann Karmanos Cancer Institute
Massachusetts General Hospital
City of Hope Medical Center
Fred Hutchinson Cancer Center